An Impaired Inflammatory Cytokine Response to Gram-Negative LPS in Human Neonates is Associated with the Defective TLR-Mediated Signaling Pathway

[1]  J. Remington,et al.  Infections diseases of the fetus and newborn infant , 2013 .

[2]  S. Liao,et al.  Maturation of Toll-like receptor 1-4 responsiveness during early life. , 2013, Early human development.

[3]  S. Blankson,et al.  Inefficient antimicrobial functions of innate phagocytes render infant mice more susceptible to bacterial infection , 2013, European journal of immunology.

[4]  Jamie Perin,et al.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 , 2012, The Lancet.

[5]  Joy E. Lawn,et al.  Neonatal Mortality Levels for 193 Countries in 2009 with Trends since 1990: A Systematic Analysis of Progress, Projections, and Priorities , 2011, PLoS medicine.

[6]  L. Moldawer,et al.  Critical Role for CXC Ligand 10/CXC Receptor 3 Signaling in the Murine Neonatal Response to Sepsis , 2011, Infection and Immunity.

[7]  Y. Carlier,et al.  Natural Killer Cell Responses to Infections in Early Life , 2011, Journal of Innate Immunity.

[8]  H. Zola,et al.  Expression of Toll‐like receptors by neonatal leukocytes , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[9]  O. Ramilo,et al.  Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.

[10]  S. McCarthy,et al.  Differences in innate immune function between allergic and nonallergic children: new insights into immune ontogeny. , 2011, The Journal of allergy and clinical immunology.

[11]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[12]  H. Hill,et al.  Multiplex Analysis of Toll-Like Receptor-Stimulated Neonatal Cytokine Response , 2009, Neonatology.

[13]  S. Self,et al.  Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults1 , 2009, The Journal of Immunology.

[14]  T. Koru-Sengul,et al.  Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants. , 2009, Blood.

[15]  C. Siegrist,et al.  B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.

[16]  Li-Sheng Lu,et al.  Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function , 2009, The Journal of experimental medicine.

[17]  L. Moldawer,et al.  Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. , 2008, Blood.

[18]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[19]  A. Prusa,et al.  Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. , 2007, Journal of Infectious Diseases.

[20]  L. Maródi.  Neonatal Innate Immunity to Infectious Agents , 2006, Infection and Immunity.

[21]  D. Viemann,et al.  Expression of Toll-Like Receptors in Neonatal Sepsis , 2005, Pediatric Research.

[22]  O. Levy.  Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists , 2005, Journal of endotoxin research.

[23]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.

[24]  O. Levy,et al.  Selective Impairment of TLR-Mediated Innate Immunity in Human Newborns: Neonatal Blood Plasma Reduces Monocyte TNF-α Induction by Bacterial Lipopeptides, Lipopolysaccharide, and Imiquimod, but Preserves the Response to R-8481 , 2004, The Journal of Immunology.

[25]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[26]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[27]  R. Medzhitov,et al.  Regulation of Phagosome Maturation by Signals from Toll-Like Receptors , 2004, Science.

[28]  A. Stadnyk,et al.  Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide , 2004, Infection and Immunity.

[29]  Jonathan M Irish,et al.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.

[30]  R. Medzhitov,et al.  Recognition of microbial infection by Toll-like receptors. , 2003, Current opinion in immunology.

[31]  S. Akira,et al.  Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.

[32]  R. Landmann,et al.  CD14, new aspects of ligand and signal diversity. , 2000, Microbes and infection.

[33]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[34]  S. Wright,et al.  Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses , 1995, The Journal of experimental medicine.

[35]  J. Cavaillon,et al.  Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.

[36]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[37]  Christopher B Wilson,et al.  Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection , 2006 .

[38]  M. Gahr,et al.  Reduced secretion of interleukin-1 and tumor necrosis factor-alpha by neonatal monocytes. , 1993, Biology of the neonate.

[39]  M. Gahr,et al.  Reduced Secretion of lnterleukin-1 and Tumor Necrosis Factor-a by Neonatal Monocytes , 1993 .